PortfoliosLab logoPortfoliosLab logo
VERA vs. CDNS
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

VERA vs. CDNS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vera Therapeutics, Inc. (VERA) and Cadence Design Systems, Inc. (CDNS). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

VERA vs. CDNS - Yearly Performance Comparison


2026 (YTD)20252024202320222021
VERA
Vera Therapeutics, Inc.
-20.02%19.74%174.97%-20.52%-27.58%132.35%
CDNS
Cadence Design Systems, Inc.
-10.36%4.03%10.31%69.55%-13.80%49.94%

Fundamentals

Market Cap

VERA:

$2.60B

CDNS:

$76.47B

EPS

VERA:

-$4.68

CDNS:

$4.06

PB Ratio

VERA:

4.30

CDNS:

10.76

Total Revenue (TTM)

VERA:

$0.00

CDNS:

$5.30B

Gross Profit (TTM)

VERA:

$0.00

CDNS:

$5.09B

EBITDA (TTM)

VERA:

-$315.47M

CDNS:

$1.74B

Returns By Period

In the year-to-date period, VERA achieves a -20.02% return, which is significantly lower than CDNS's -10.36% return.


VERA

1D
0.67%
1M
0.20%
YTD
-20.02%
6M
40.67%
1Y
83.92%
3Y*
73.46%
5Y*
10Y*

CDNS

1D
0.83%
1M
-7.64%
YTD
-10.36%
6M
-20.39%
1Y
8.27%
3Y*
10.07%
5Y*
14.64%
10Y*
28.05%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

VERA vs. CDNS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VERA
VERA Risk / Return Rank: 7474
Overall Rank
VERA Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
VERA Sortino Ratio Rank: 8181
Sortino Ratio Rank
VERA Omega Ratio Rank: 7878
Omega Ratio Rank
VERA Calmar Ratio Rank: 7373
Calmar Ratio Rank
VERA Martin Ratio Rank: 6868
Martin Ratio Rank

CDNS
CDNS Risk / Return Rank: 4747
Overall Rank
CDNS Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
CDNS Sortino Ratio Rank: 4444
Sortino Ratio Rank
CDNS Omega Ratio Rank: 4343
Omega Ratio Rank
CDNS Calmar Ratio Rank: 5050
Calmar Ratio Rank
CDNS Martin Ratio Rank: 4949
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VERA vs. CDNS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vera Therapeutics, Inc. (VERA) and Cadence Design Systems, Inc. (CDNS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


VERACDNSDifference

Sharpe ratio

Return per unit of total volatility

0.89

0.21

+0.68

Sortino ratio

Return per unit of downside risk

2.21

0.60

+1.61

Omega ratio

Gain probability vs. loss probability

1.28

1.08

+0.20

Calmar ratio

Return relative to maximum drawdown

1.72

0.36

+1.36

Martin ratio

Return relative to average drawdown

3.23

0.80

+2.43

VERA vs. CDNS - Sharpe Ratio Comparison

The current VERA Sharpe Ratio is 0.89, which is higher than the CDNS Sharpe Ratio of 0.21. The chart below compares the historical Sharpe Ratios of VERA and CDNS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


VERACDNSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.89

0.21

+0.68

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.42

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.84

Sharpe Ratio (All Time)

Calculated using the full available price history

0.32

0.22

+0.10

Correlation

The correlation between VERA and CDNS is 0.20, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

VERA vs. CDNS - Dividend Comparison

Neither VERA nor CDNS has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

VERA vs. CDNS - Drawdown Comparison

The maximum VERA drawdown since its inception was -84.89%, smaller than the maximum CDNS drawdown of -93.13%. Use the drawdown chart below to compare losses from any high point for VERA and CDNS.


Loading graphics...

Drawdown Indicators


VERACDNSDifference

Max Drawdown

Largest peak-to-trough decline

-84.89%

-93.13%

+8.24%

Max Drawdown (1Y)

Largest decline over 1 year

-39.83%

-28.09%

-11.74%

Max Drawdown (5Y)

Largest decline over 5 years

-29.59%

Max Drawdown (10Y)

Largest decline over 10 years

-32.12%

Current Drawdown

Current decline from peak

-27.25%

-24.96%

-2.29%

Average Drawdown

Average peak-to-trough decline

-40.29%

-39.79%

-0.50%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.24%

12.71%

+8.53%

Volatility

VERA vs. CDNS - Volatility Comparison

Vera Therapeutics, Inc. (VERA) has a higher volatility of 13.53% compared to Cadence Design Systems, Inc. (CDNS) at 7.54%. This indicates that VERA's price experiences larger fluctuations and is considered to be riskier than CDNS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


VERACDNSDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.53%

7.54%

+5.99%

Volatility (6M)

Calculated over the trailing 6-month period

43.63%

25.41%

+18.22%

Volatility (1Y)

Calculated over the trailing 1-year period

94.76%

39.60%

+55.16%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

92.50%

35.24%

+57.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

92.50%

33.42%

+59.08%

Financials

VERA vs. CDNS - Financials Comparison

This section allows you to compare key financial metrics between Vera Therapeutics, Inc. and Cadence Design Systems, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober0
1.44B
(VERA) Total Revenue
(CDNS) Total Revenue
Values in USD except per share items